The study consisted of two components: in the preclinical phase, Apc gene-knockout mice, a model for sporadic CRC, were treated with losartan alone, vitamin D alone, losartan + vitamin D, or vehicle; in the clinical phase, 40 patients with early-stage CRC were administered either the losartan–vitamin D combination or standard surveillance. Here, APC is linked to colorectal carcinoma.